Canada markets close in 2 hours 18 minutes

Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
2.110-0.040 (-1.86%)
At close: 03:18PM HKT
Full screen
Previous Close2.150
Open2.200
Bid2.110 x N/A
Ask2.120 x N/A
Day's Range2.110 - 2.200
52 Week Range1.790 - 6.770
Volume22,700
Avg. Volume32,824
Market Cap529.886M
Beta (5Y Monthly)-0.47
PE Ratio (TTM)N/A
EPS (TTM)-0.790
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    Bioheart (02185.HK) announces clinical result for Iberis-HTN at CIT 2023

    Bioheart (02185.HK), together with its holding subsidiary Angiocare announces the clinical result for Iberis-HTN at China Interventional Therapeutics 2023. Iberis-HTN is a prospective, multicenter, blinded, randomized controlled trial to evaluate the safety and efficacy of the Iberis® Multi-Electrode Renal Artery Radiofrequency Ablation Catheter System for the treatment of primary hypertension (NCT02901704). The study was led by Academician Runlin GAO and Professor Xiongjing JIANG from Fuwai Hos